Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Viemed Healthcare (VMD) Shares Issued (2019 - 2026)

Viemed Healthcare filings provide 7 years of Shares Issued readings, the most recent being $71000.0 for Q3 2025.

  • On a quarterly basis, Shares Issued fell 21.98% to $71000.0 in Q3 2025 year-over-year; TTM through Dec 2025 was $1.4 million, a 41.49% increase, with the full-year FY2025 number at $1.4 million, up 41.49% from a year prior.
  • Shares Issued hit $71000.0 in Q3 2025 for Viemed Healthcare, down from $1.4 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $1.4 million in Q2 2025 to a low of $6000.0 in Q3 2023.
  • Median Shares Issued over the past 5 years was $87000.0 (2022), compared with a mean of $276933.3.
  • Biggest five-year swings in Shares Issued: crashed 97.32% in 2021 and later surged 6361.9% in 2025.
  • Viemed Healthcare's Shares Issued stood at $47000.0 in 2021, then soared by 317.02% to $196000.0 in 2022, then plummeted by 64.8% to $69000.0 in 2023, then surged by 771.01% to $601000.0 in 2024, then plummeted by 88.19% to $71000.0 in 2025.
  • The last three reported values for Shares Issued were $71000.0 (Q3 2025), $1.4 million (Q2 2025), and $11000.0 (Q1 2025) per Business Quant data.